Change of Director's Interest Notice - C. Stevens
Released
Released
Announcement PDF
Appendix 3Y
Change of Director’s Interest Notice
Appendix 3Y
Rule 3.19A.2
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity Coda Minerals Ltd
ABN
49 625 763 957
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.
Name of Director
Christopher Stevens
Date of last notice
14 July 2022
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Direct or indirect interest
Indirect
Nature of indirect interest
(including registered holder)
Dr Catriona Fleur Stevens - spouse
Note: Provide details of the circumstances giving rise to the relevant
interest.
Date of change
17 November 2022
No. of securities held prior to change
Direct
Christopher Stevens
358,174 fully paid ordinary shares
Indirect
Dr Catriona Fleur Stevens – spouse
34,415 fully paid ordinary shares
2,000,000 options, exercise price $0.2145
and expiring on 3 July 2024
68,831 2021 Performance Rights
Class
2022 Performance Rights
Number acquired
471,602 2022 Performance Rights
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y
Change of Director’s Interest Notice
Number disposed
Nil
Value/Consideration
Nil - performance rights issued in
accordance with shareholder approval
obtained at the AGM held on 9 November
2022.
Note: If consideration is non-cash, provide details and estimated
valuation
No. of securities held after change
Direct
Christopher Stevens
358,174 fully paid ordinary shares
Indirect
Dr Catriona Fleur Stevens – spouse
34,415 fully paid ordinary shares
2,000,000 options, exercise price $0.2145
and expiring on 3 July 2024
68,831 2021 Performance Rights
471,602 2022 Performance Rights
Nature of change
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation in
buy-back
Issue of 471,602 performance rights in
accordance with shareholder approval
obtained at the AGM held on 9 November
2022.
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Detail of contract
N/A
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
Interest disposed
+ See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y
Change of Director’s Interest Notice
Value/Consideration
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change
Part 3 – +Closed period
Were the interests in the securities or contracts detailed No
above traded during a +closed period where prior written
clearance was required?
If so, was prior written clearance provided to allow the trade N/A
to proceed during this period?
If prior written clearance was provided, on what date was this N/A
provided?
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3
Share your feedback
Discover